Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 510.00
Ask: 520.00
Change: -10.00 (-1.92%)
Spread: 10.00 (1.961%)
Open: 526.00
High: 526.00
Low: 510.00
Prev. Close: 520.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jan 2014 07:00

RNS Number : 6626X
Zotefoams PLC
15 January 2014
 



 

Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

15 January 2014 - Zotefoams, a world leader in cellular material technology, today provides a trading update following the Company's financial year end on 31 December 2013.

 

In the fourth quarter Zotefoams continued to experience good growth in sales of High-Performance Products ("HPP"), which was augmented by strong growth in our MuCell Extrusion ("MEL") technology licensing business. However, as anticipated in our Third Quarter Interim Management Statement dated 23 October 2013, the fourth quarter saw lower levels of shipments of polyolefin foams to Europe. This fall is, in the main, related to inventory adjustments at a single large customer who reports that this is due to improved lead times from Zotefoams and continued destocking in their downstream market, affecting their demand levels in the short-term. As stated on 23 October 2013, with the benefit of our shorter lead times, we expect to progress in this market in 2014.

 

For the 2013 full year we expect to see growth in HPP and MEL, although overall Group sales are expected to show a decline of approximately 5% compared with 2012, mainly as a result of lower polyolefin sales in continental Europe.

 

For the fourth quarter the euro-denominated price of low density polyethylene (LDPE), our major raw material, remained at a similar average price to the first nine months of the year. Exchange rates were similar to those reported in October with a slight strengthening of sterling in the period, particularly against the US dollar.

 

Overall the Board expects an outcome for 2013 broadly in line with management expectations.

 

The Company intends to announce its preliminary results for the year ended 31 December 2013 on Tuesday, 18 March 2014.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGMMLDRGDZM
Date   Source Headline
21st Dec 20055:32 pmRNSHolding(s) in Company
15th Dec 20057:00 amRNSPeriod End Trading Update
12th Dec 20054:12 pmRNSBlocklisting Interim Review
22nd Nov 200511:37 amRNSDirector/PDMR Shareholding
2nd Nov 20057:01 amRNSTrading Statement
26th Aug 200512:00 pmRNSUpdate on Directorate
18th Aug 20057:00 amRNSUpdate on Discussions
18th Aug 20057:00 amRNSInterim Results
3rd Aug 200511:23 amRNSRule 8.1- Zotefoams PLC
2nd Aug 200511:14 amRNSRule 8.1- Zotefoams PLC
20th Jul 200511:49 amRNSRule 8.1- Zotefoams PLC
9th Jun 20058:36 amRNSAdditional Listing
3rd May 20055:00 pmRNSHolding(s) in Company
28th Apr 20057:03 amRNSAGM Statement
24th Mar 200511:59 amRNSDocuments on Display
8th Mar 20057:01 amRNSFinal Results
17th Jan 200511:43 amRNSRule 2.10 Announcement
14th Jan 200510:19 amRNSStatement re Possible Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.